Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Enzyme (MLN) vs Sui (SUI) Price & Performance

EnzymeTrade

Price performance (Past 24H)

Key statistics

Enzyme vs Sui — how do they compare? Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume), while Sui trades at Rp13,700 (market cap Rp56,02T, Rp3,6T 24h volume). The key difference: Sui is far larger — about 417654.5× Enzyme's market cap, and Sui's supply is capped (4,1B / 10B SUI (41%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Enzyme for 28 Days and Sui for 35 Days on average.

MLNSUI
Market Cap
Rp134,13MRp56,02T
Volume (24h)
Rp104,56MRp3,6T
Circulating Supply
3,3M MLN4,1B / 10B SUI (41%)
Typical Hold Time
28 Days35 Days

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Enzyme

Enzyme (MLN) currently holds a market capitalization of Rp134.13 million with a circulating supply of 3.3 million tokens. The asset shows moderate market activity with a hold time of 28 days indicating average investor retention. Recent market data suggests stable trading patterns within the decentralized finance ecosystem, though specific price action requires current exchange verification.

Outlook remains cautiously neutral given limited recent protocol updates. Key opportunities include potential DeFi ecosystem growth integration, while risks center on typical crypto volatility and regulatory uncertainty. Investors should monitor on-chain activity and exchange liquidity for clearer directional signals.

Sui

Sui is currently trading at Rp13,524 with a market cap of Rp54.78T, showing bullish technical signals across moving averages and oscillators. The token maintains 41% circulation with strong ADX indicators suggesting trending momentum. Recent ecosystem growth includes developer activity and protocol optimizations, though RSI levels indicate potential short-term overbought conditions. Support levels are established at Rp12,434-13,576 while resistance sits at Rp14,122-14,966.

Overall outlook remains cautiously bullish with strong technical momentum but faces overbought risks near-term. Key opportunities include continued ecosystem expansion and developer adoption, while major risks involve regulatory uncertainty and typical crypto volatility. Investors should monitor support levels closely given current RSI readings.

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

MLN

No sentiment data available yet.

SUI
31% Buy69% Sell
Avg holding period · 35 Days

Top news

Latest headlines on both assets

About Enzyme

Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.

Read more on MLN

About Sui

Sui is a first-of-its-kind Layer-1 blockchain and smart contract platform designed from the bottom up to make digital asset ownership fast, private, secure, and accessible to everyone. Based on the Move programming language, its object-centric model enables parallel execution, sub-second finality, and rich on-chain assets. Sui supports a wide range of applications with unrivaled speed at a low cost.

Read more on SUI